Home > Insider Trading > Filing (0001181431-13-031298)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1269021	Portola Pharmaceuticals Inc	PTLA	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1512375	Ltd Pte (Mauritius) Maxwell	Les Cascades, Edith Cavell St Port Louis O4 NA		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-05-28	3,533,568	$0.00	3,533,568	No	4	C	Direct
Common Stock	Acquisiton	2013-05-28	700,000	$14.50	4,233,568	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Direct
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series D Convertible Preferred Stock	Disposition	2013-05-28	3,533,568	$0.00	3,533,568	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Direct

Footnotes

Maxwell (Mauritius) Pte. Ltd. directly owns 3,533,568 shares of Issuer's Series D Convertible Preferred Stock. Maxwell (Mauritius) Pte. Ltd. is wholly owned by Cairnhill Investments (Mauritius) Pte. Ltd., which is wholly owned by Fullerton Management Pte. Ltd., which is wholly owned by Temasek Holdings (Private) Limited. Each of Cairnhill, Fullerton or Temasek, through the ownership described herein, may be deemed to beneficially own the shares held by Maxwell (Mauritius) Pte. Ltd.
Each share of the issuer's Series D Convertible Preferred Stock automatically converted into one share of common stock upon the closing of the issuer's initial public offering and has no expiration date.